BeStock  
Stocks › Biotechnology › GHRS

GH Research GHRS

US equityMarket cap rank #3039Biotechnology
$17.53 −$1.03 (-5.55%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $17.53 0.00%
Open$18.32
Prev close$18.56
Day range$17.29 – $18.32
Volume299.5K
Market cap$1.20B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$50.33+187.1% vs. price
  • Buy 100%
Low $42.00Now $17.53Avg $50.33High $65.00

Recent rating changes

The last 20 actions on file set price targets from $32.00 to $65.00, averaging $43.33.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $65.00
9 Nov 2026 RBC Capital BUY $42.00
31 Aug 2026 Wells Fargo BUY $44.00
10 Aug 2026 H.C. Wainwright BUY $65.00
6 Aug 2026 TD Cowen BUY –
6 Aug 2026 Cantor Fitzgerald BUY $40.00
6 Aug 2026 CCORF BUY $39.00
6 Aug 2026 Stifel BUY $38.00
6 Aug 2026 Needham BUY $39.00
6 Aug 2026 Guggenheim BUY $40.00
6 Aug 2026 RBC Capital BUY $42.00
27 Jul 2026 Wells Fargo BUY $44.00
19 May 2026 H.C. Wainwright BUY $65.00
15 May 2026 Cantor Fitzgerald BUY $35.00
15 May 2026 CCORF BUY $39.00
15 May 2026 Citizens JMP BUY $39.00
15 May 2026 Needham BUY $32.00
14 May 2026 TD Cowen BUY –
14 May 2026 Needham BUY $32.00
14 May 2026 RBC Capital BUY $40.00

Discussion

No comments yet — be the first to weigh in on GHRS.

Sign in to join the discussion.

Scroll to Top